VRK1
protein-codingVRK serine/threonine kinase 1
Gene summary
This gene encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. This gene is widely expressed in human tissues and has increased expression in actively dividing cells, such as those in testis, thymus, fetal liver, and carcinomas. Its protein localizes to the nucleus and has been shown to promote the stability and nuclear accumulation of a transcriptionally active p53 molecule and, in vitro, to phosphorylate Thr18 of p53 and reduce p53 ubiquitination. This gene, therefore, may regulate cell proliferation. This protein also phosphorylates histone, casein, and the transcription factors ATF2 (activating transcription factor 2) and c-JUN. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~157.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0011866
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0011866
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0957876
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0016396
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011866
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0018507
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011866
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0011866
Submitter: Natera
Inheritance Pattern: AR
Disease ID:MONDO:0011866
Submitter: Genomics England PanelApp
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to VRK1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003384.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 133 | 139 | |||
| missense | 1 | 12 | 149 | 4 | 166 | |
| nonsense | 13 | 8 | 21 | |||
| start loss | 1 | 1 | ||||
| frameshift | 22 | 25 | 2 | 49 | ||
| splice donor/acceptor (+/-2bp) | 2 | 19 | 2 | 23 | ||
| Total | 38 | 64 | 160 | 137 | 0 | 399 |
Highest pathogenic variant AF is 0.000047914946
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003375.1 | 12 | MANE Select | |
| Ensembl | ENSP00000216639.3 | 12 | MANE Select | |
| RefSeq | NP_001397980.1 | 13 | Standard | |
| RefSeq | NP_001397982.1 | 12 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Clearance of Nuclear Envelope Membranes from Chromatin
- Nuclear Envelope Breakdown
- Mitotic Prophase
- Initiation of Nuclear Envelope Reformation
- Nuclear Envelope Reassembly
Biological Process
- protein phosphorylation
- mitotic nuclear envelope disassembly
- mitotic nuclear envelope reassembly
- peptidyl-serine phosphorylation
- peptidyl-threonine phosphorylation
Molecular Function
- protein kinase activity
- protein serine/threonine kinase activity
- protein binding
- ATP binding
- protein kinase binding
Cellular Component
- nucleus
- nucleoplasm
- nucleolus
- cytoplasm
- Golgi stack
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000216639
- Coding exons
- 12
- Length
- 134419
- Individuals with no LoFs
- 125710
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 36
- Defined
- 125746
- p
- 0.000143
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.17 | 167 | 215 | 0.776 | 0.0000113 | 2603 |
| Missense (PolyPhen) | 30 | 58.009 | 0.51716 | 678 | ||
| Synonymous | 0.570 | 61 | 66.9 | 0.911 | 0.00000330 | 688 |
| Loss of Function | 2.94 | 9 | 24.8 | 0.363 | 0.00000133 | 308 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0.0016 | 0.0016 | notable |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000098 | 0.000097 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0.00036 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Serine/threonine kinase involved in Golgi disassembly during the cell cycle: following phosphorylation by PLK3 during mitosis, required to induce Golgi fragmentation. Acts by mediating phosphorylation of downstream target protein. Phosphorylates 'Thr- 18' of p53/TP53 and may thereby prevent the interaction between p53/TP53 and MDM2. Phosphorylates casein and histone H3. Phosphorylates BANF1: disrupts its ability to bind DNA, reduces its binding to LEM domain-containing proteins and causes its relocalization from the nucleus to the cytoplasm. Phosphorylates ATF2 which activates its transcriptional activity. {ECO:0000269|PubMed:10951572, ECO:0000269|PubMed:14645249, ECO:0000269|PubMed:15105425, ECO:0000269|PubMed:16495336, ECO:0000269|PubMed:18617507, ECO:0000269|PubMed:19103756}.;
- Disease
- DISEASE: Pontocerebellar hypoplasia 1A (PCH1A) [MIM:607596]: A disorder characterized by an abnormally small cerebellum and brainstem, central and peripheral motor dysfunction from birth, gliosis and spinal cord anterior horn cells degeneration resembling infantile spinal muscular atrophy. Additional features include muscle hypotonia, congenital contractures and respiratory insufficiency that is evident at birth. {ECO:0000269|PubMed:19646678}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- LoFtool
- 0.848
- RVIS EVS
- -0.38
- RVIS percentile EVS
- 27.69
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- E
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.966
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |